container_end_page 673
container_issue 8
container_start_page 672
container_title JAMA : the journal of the American Medical Association
container_volume 332
creator Kurian, Marina
Rogers, Ann M
Peterson, Richard M
description
doi_str_mv 10.1001/jama.2024.12071
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3086387130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2821636</ama_id><sourcerecordid>3086387130</sourcerecordid><originalsourceid>FETCH-LOGICAL-a200t-5eef626683bea2acfa68d9aa4c84c0e8ce0a3496d59b0e5708bbd946d2bd9d163</originalsourceid><addsrcrecordid>eNo9kEFPwkAQRjdGI4ieTTgYjl4Kszvb7eyREEUTEjzoebNtp6aEUuyWA__eVsC5fId532TyhHiUMJUAcrbxlZ8qUHoqFSTySgxljBRhbOlaDAEsRYkmPRB3IWygG4nJrRigBUJFOBTj5eojkpP5d70rQxsmRd1M1imHsj3ei5vCbwM_nHMkvl5fPhdv0Wq9fF_MV5FXAG0UMxdGGUOYslc-K7yh3HqvM9IZMGUMHrU1eWxT4DgBStPcapOrLnJpcCSeT3f3Tf1z4NC6qgwZb7d-x_UhOAQySIlE6NDZCc2aOoSGC7dvyso3RyfB9UJcL8T1QtyfkK7xdD5-SCvO__mLgQ4Yn4C-eNkqUt1jBn8BrEtiWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3086387130</pqid></control><display><type>article</type><title>GLP-1 Agonists for Obesity</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Kurian, Marina ; Rogers, Ann M ; Peterson, Richard M</creator><creatorcontrib>Kurian, Marina ; Rogers, Ann M ; Peterson, Richard M</creatorcontrib><identifier>ISSN: 0098-7484</identifier><identifier>ISSN: 1538-3598</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2024.12071</identifier><identifier>PMID: 39083283</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Anti-Obesity Agents - administration &amp; dosage ; Anti-Obesity Agents - adverse effects ; Anti-Obesity Agents - economics ; Bariatric Surgery - statistics &amp; numerical data ; Glucagon-Like Peptide-1 Receptor - agonists ; Glucagon-Like Peptide-1 Receptor Agonists - administration &amp; dosage ; Glucagon-Like Peptide-1 Receptor Agonists - adverse effects ; Glucagon-Like Peptide-1 Receptor Agonists - economics ; Health Services Misuse - statistics &amp; numerical data ; Humans ; Insurance Coverage - economics ; Insurance, Health - economics ; Insurance, Health - statistics &amp; numerical data ; Obesity - drug therapy ; Obesity - economics ; Obesity - surgery ; Weight Loss - drug effects</subject><ispartof>JAMA : the journal of the American Medical Association, 2024-08, Vol.332 (8), p.672-673</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a200t-5eef626683bea2acfa68d9aa4c84c0e8ce0a3496d59b0e5708bbd946d2bd9d163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.2024.12071$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.12071$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,776,780,3327,27901,27902,76231,76234</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39083283$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kurian, Marina</creatorcontrib><creatorcontrib>Rogers, Ann M</creatorcontrib><creatorcontrib>Peterson, Richard M</creatorcontrib><title>GLP-1 Agonists for Obesity</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><subject>Anti-Obesity Agents - administration &amp; dosage</subject><subject>Anti-Obesity Agents - adverse effects</subject><subject>Anti-Obesity Agents - economics</subject><subject>Bariatric Surgery - statistics &amp; numerical data</subject><subject>Glucagon-Like Peptide-1 Receptor - agonists</subject><subject>Glucagon-Like Peptide-1 Receptor Agonists - administration &amp; dosage</subject><subject>Glucagon-Like Peptide-1 Receptor Agonists - adverse effects</subject><subject>Glucagon-Like Peptide-1 Receptor Agonists - economics</subject><subject>Health Services Misuse - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Insurance Coverage - economics</subject><subject>Insurance, Health - economics</subject><subject>Insurance, Health - statistics &amp; numerical data</subject><subject>Obesity - drug therapy</subject><subject>Obesity - economics</subject><subject>Obesity - surgery</subject><subject>Weight Loss - drug effects</subject><issn>0098-7484</issn><issn>1538-3598</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEFPwkAQRjdGI4ieTTgYjl4Kszvb7eyREEUTEjzoebNtp6aEUuyWA__eVsC5fId532TyhHiUMJUAcrbxlZ8qUHoqFSTySgxljBRhbOlaDAEsRYkmPRB3IWygG4nJrRigBUJFOBTj5eojkpP5d70rQxsmRd1M1imHsj3ei5vCbwM_nHMkvl5fPhdv0Wq9fF_MV5FXAG0UMxdGGUOYslc-K7yh3HqvM9IZMGUMHrU1eWxT4DgBStPcapOrLnJpcCSeT3f3Tf1z4NC6qgwZb7d-x_UhOAQySIlE6NDZCc2aOoSGC7dvyso3RyfB9UJcL8T1QtyfkK7xdD5-SCvO__mLgQ4Yn4C-eNkqUt1jBn8BrEtiWA</recordid><startdate>20240827</startdate><enddate>20240827</enddate><creator>Kurian, Marina</creator><creator>Rogers, Ann M</creator><creator>Peterson, Richard M</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240827</creationdate><title>GLP-1 Agonists for Obesity</title><author>Kurian, Marina ; Rogers, Ann M ; Peterson, Richard M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a200t-5eef626683bea2acfa68d9aa4c84c0e8ce0a3496d59b0e5708bbd946d2bd9d163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anti-Obesity Agents - administration &amp; dosage</topic><topic>Anti-Obesity Agents - adverse effects</topic><topic>Anti-Obesity Agents - economics</topic><topic>Bariatric Surgery - statistics &amp; numerical data</topic><topic>Glucagon-Like Peptide-1 Receptor - agonists</topic><topic>Glucagon-Like Peptide-1 Receptor Agonists - administration &amp; dosage</topic><topic>Glucagon-Like Peptide-1 Receptor Agonists - adverse effects</topic><topic>Glucagon-Like Peptide-1 Receptor Agonists - economics</topic><topic>Health Services Misuse - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Insurance Coverage - economics</topic><topic>Insurance, Health - economics</topic><topic>Insurance, Health - statistics &amp; numerical data</topic><topic>Obesity - drug therapy</topic><topic>Obesity - economics</topic><topic>Obesity - surgery</topic><topic>Weight Loss - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kurian, Marina</creatorcontrib><creatorcontrib>Rogers, Ann M</creatorcontrib><creatorcontrib>Peterson, Richard M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kurian, Marina</au><au>Rogers, Ann M</au><au>Peterson, Richard M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GLP-1 Agonists for Obesity</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2024-08-27</date><risdate>2024</risdate><volume>332</volume><issue>8</issue><spage>672</spage><epage>673</epage><pages>672-673</pages><issn>0098-7484</issn><issn>1538-3598</issn><eissn>1538-3598</eissn><cop>United States</cop><pub>American Medical Association</pub><pmid>39083283</pmid><doi>10.1001/jama.2024.12071</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0098-7484
ispartof JAMA : the journal of the American Medical Association, 2024-08, Vol.332 (8), p.672-673
issn 0098-7484
1538-3598
1538-3598
language eng
recordid cdi_proquest_miscellaneous_3086387130
source MEDLINE; American Medical Association Journals
subjects Anti-Obesity Agents - administration & dosage
Anti-Obesity Agents - adverse effects
Anti-Obesity Agents - economics
Bariatric Surgery - statistics & numerical data
Glucagon-Like Peptide-1 Receptor - agonists
Glucagon-Like Peptide-1 Receptor Agonists - administration & dosage
Glucagon-Like Peptide-1 Receptor Agonists - adverse effects
Glucagon-Like Peptide-1 Receptor Agonists - economics
Health Services Misuse - statistics & numerical data
Humans
Insurance Coverage - economics
Insurance, Health - economics
Insurance, Health - statistics & numerical data
Obesity - drug therapy
Obesity - economics
Obesity - surgery
Weight Loss - drug effects
title GLP-1 Agonists for Obesity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A51%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GLP-1%20Agonists%20for%20Obesity&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Kurian,%20Marina&rft.date=2024-08-27&rft.volume=332&rft.issue=8&rft.spage=672&rft.epage=673&rft.pages=672-673&rft.issn=0098-7484&rft.eissn=1538-3598&rft_id=info:doi/10.1001/jama.2024.12071&rft_dat=%3Cproquest_cross%3E3086387130%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3086387130&rft_id=info:pmid/39083283&rft_ama_id=2821636&rfr_iscdi=true